TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
531,845
|
635,184
|
563,609 |
| Financial expenses |
32,602
|
14,838
|
28,584 |
| Earnings before taxes |
23,924
|
27,662
|
34,131 |
| EBITDA |
79,635
|
81,681
|
100,999 |
| Total assets |
1,768,595
|
1,684,951
|
1,419,577 |
| Current assets |
818,656
|
691,567
|
384,115 |
| Current liabilities |
515,578
|
452,704
|
212,667 |
| Equity capital |
1,234,370
|
1,215,644
|
1,193,538 |
| - share capital |
317,186
|
317,186
|
317,186 |
| Employees (average) |
370
|
345
|
364 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.8%
|
72.1%
|
84.1% |
| Turnover per employee |
1,437
|
1,841
|
1,548 |
| Profit as a percentage of turnover |
4.5%
|
4.4%
|
6.1% |
| Return on assets (ROA) |
3.2%
|
2.5%
|
4.4% |
| Current ratio |
158.8%
|
152.8%
|
180.6% |
| Return on equity (ROE) |
1.9%
|
2.3%
|
2.9% |
| Change turnover |
-103,339
|
71,575
|
71,469 |
| Change turnover % |
-16%
|
13%
|
15% |
| Chg. No. of employees |
25
|
-19
|
14 |
| Chg. No. of employees % |
7%
|
-5%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.